Seroprevalence rates of varicella zoster virus antibodies

The information is intended to provide an indication of population immunity, based on antibody testing results in serum specimens received during the designated year.

Year	Age group (years)
	1-4		5-9		10-14		15-19		20-24		25-29		30-34		35-39		>39
	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%	No.	%
2000	100	25	100	65	100	84	100	97	100	95	100	99	100	94	100	99	100	95
2005	200	24.5	200	61.5	100	79	100	92	50	94	50	92	50	96	50	94	100	98
2010	200	26	200	56.5	100	77	100	88	50	94	50	90	50	96	50	96	100	98
2015	200	36	100	50	50	62	50	76	50	92	50	94	50	100	50	92	50	98
2020	195	82.1	200	53	50	52	50	76	50	82	50	90	50	94	50	88	100	97